Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified Surface
Neuronal damage secondary to traumatic brain injury (TBI) is a rapidly evolving condition, which requires therapeutic decisions based on the timely identification of clinical deterioration. Changes in S100B biomarker levels are associated with TBI severity and patient outcome. The S100B quantificati...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Sensors |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8220/21/6/1929 |
id |
doaj-2d6cb52377924e409e6abd7df726cc51 |
---|---|
record_format |
Article |
spelling |
doaj-2d6cb52377924e409e6abd7df726cc512021-03-11T00:00:16ZengMDPI AGSensors1424-82202021-03-01211929192910.3390/s21061929Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified SurfaceAlexander Rodríguez0Francisco Burgos-Flórez1José D. Posada2Eliana Cervera3Valtencir Zucolotto4Homero Sanjuán5Marco Sanjuán6Pedro J. Villalba7Biotechnology Research Group, Universidad del Norte, Barranquilla 081007, ColombiaBiotechnology Research Group, Universidad del Norte, Barranquilla 081007, ColombiaSchool of Medicine, Stanford University, Redwood City, CA 94063, USABiotechnology Research Group, Universidad del Norte, Barranquilla 081007, ColombiaGnano—Nanomedicine and Nanotoxicology Group, São Carlos Institute of Physics, University of São Paulo, São Carlos 13566-590, São Paulo, BrazilBiotechnology Research Group, Universidad del Norte, Barranquilla 081007, ColombiaRational Use of Energy and Preservation of the Environment Group (UREMA), Universidad del Norte, Barranquilla 081007, ColombiaBiotechnology Research Group, Universidad del Norte, Barranquilla 081007, ColombiaNeuronal damage secondary to traumatic brain injury (TBI) is a rapidly evolving condition, which requires therapeutic decisions based on the timely identification of clinical deterioration. Changes in S100B biomarker levels are associated with TBI severity and patient outcome. The S100B quantification is often difficult since standard immunoassays are time-consuming, costly, and require extensive expertise. A zero-length cross-linking approach on a cysteamine self-assembled monolayer (SAM) was performed to immobilize anti-S100B monoclonal antibodies onto both planar (AuEs) and interdigitated (AuIDEs) gold electrodes via carbonyl-bond. Surface characterization was performed by atomic force microscopy (AFM) and specular-reflectance FTIR for each functionalization step. Biosensor response was studied using the change in charge-transfer resistance (Rct) from electrochemical impedance spectroscopy (EIS) in potassium ferrocyanide, with [S100B] ranging 10–1000 pg/mL. A single-frequency analysis for capacitances was also performed in AuIDEs. Full factorial designs were applied to assess biosensor sensitivity, specificity, and limit-of-detection (LOD). Higher Rct values were found with increased S100B concentration in both platforms. LODs were 18 pg/mL(AuES) and 6 pg/mL(AuIDEs). AuIDEs provide a simpler manufacturing protocol, with reduced fabrication time and possibly costs, simpler electrochemical response analysis, and could be used for single-frequency analysis for monitoring capacitance changes related to S100B levels.https://www.mdpi.com/1424-8220/21/6/1929biosensorgold electrodeselectrochemical impedance spectroscopybrain injuriesS-100Bbiomarker |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Alexander Rodríguez Francisco Burgos-Flórez José D. Posada Eliana Cervera Valtencir Zucolotto Homero Sanjuán Marco Sanjuán Pedro J. Villalba |
spellingShingle |
Alexander Rodríguez Francisco Burgos-Flórez José D. Posada Eliana Cervera Valtencir Zucolotto Homero Sanjuán Marco Sanjuán Pedro J. Villalba Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified Surface Sensors biosensor gold electrodes electrochemical impedance spectroscopy brain injuries S-100B biomarker |
author_facet |
Alexander Rodríguez Francisco Burgos-Flórez José D. Posada Eliana Cervera Valtencir Zucolotto Homero Sanjuán Marco Sanjuán Pedro J. Villalba |
author_sort |
Alexander Rodríguez |
title |
Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified Surface |
title_short |
Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified Surface |
title_full |
Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified Surface |
title_fullStr |
Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified Surface |
title_full_unstemmed |
Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified Surface |
title_sort |
electrochemical immunosensor for the quantification of s100b at clinically relevant levels using a cysteamine modified surface |
publisher |
MDPI AG |
series |
Sensors |
issn |
1424-8220 |
publishDate |
2021-03-01 |
description |
Neuronal damage secondary to traumatic brain injury (TBI) is a rapidly evolving condition, which requires therapeutic decisions based on the timely identification of clinical deterioration. Changes in S100B biomarker levels are associated with TBI severity and patient outcome. The S100B quantification is often difficult since standard immunoassays are time-consuming, costly, and require extensive expertise. A zero-length cross-linking approach on a cysteamine self-assembled monolayer (SAM) was performed to immobilize anti-S100B monoclonal antibodies onto both planar (AuEs) and interdigitated (AuIDEs) gold electrodes via carbonyl-bond. Surface characterization was performed by atomic force microscopy (AFM) and specular-reflectance FTIR for each functionalization step. Biosensor response was studied using the change in charge-transfer resistance (Rct) from electrochemical impedance spectroscopy (EIS) in potassium ferrocyanide, with [S100B] ranging 10–1000 pg/mL. A single-frequency analysis for capacitances was also performed in AuIDEs. Full factorial designs were applied to assess biosensor sensitivity, specificity, and limit-of-detection (LOD). Higher Rct values were found with increased S100B concentration in both platforms. LODs were 18 pg/mL(AuES) and 6 pg/mL(AuIDEs). AuIDEs provide a simpler manufacturing protocol, with reduced fabrication time and possibly costs, simpler electrochemical response analysis, and could be used for single-frequency analysis for monitoring capacitance changes related to S100B levels. |
topic |
biosensor gold electrodes electrochemical impedance spectroscopy brain injuries S-100B biomarker |
url |
https://www.mdpi.com/1424-8220/21/6/1929 |
work_keys_str_mv |
AT alexanderrodriguez electrochemicalimmunosensorforthequantificationofs100batclinicallyrelevantlevelsusingacysteaminemodifiedsurface AT franciscoburgosflorez electrochemicalimmunosensorforthequantificationofs100batclinicallyrelevantlevelsusingacysteaminemodifiedsurface AT josedposada electrochemicalimmunosensorforthequantificationofs100batclinicallyrelevantlevelsusingacysteaminemodifiedsurface AT elianacervera electrochemicalimmunosensorforthequantificationofs100batclinicallyrelevantlevelsusingacysteaminemodifiedsurface AT valtencirzucolotto electrochemicalimmunosensorforthequantificationofs100batclinicallyrelevantlevelsusingacysteaminemodifiedsurface AT homerosanjuan electrochemicalimmunosensorforthequantificationofs100batclinicallyrelevantlevelsusingacysteaminemodifiedsurface AT marcosanjuan electrochemicalimmunosensorforthequantificationofs100batclinicallyrelevantlevelsusingacysteaminemodifiedsurface AT pedrojvillalba electrochemicalimmunosensorforthequantificationofs100batclinicallyrelevantlevelsusingacysteaminemodifiedsurface |
_version_ |
1724226436295819264 |